Načítá se...
Buprenorphine dosing for the treatment of opioid use disorder through pregnancy and postpartum
PURPOSE OF REVIEW: Opioid-related deaths are a leading cause of mortality during pregnancy through 12 months postpartum. Buprenorphine use during pregnancy is increasing, yet expert opinion on its dosing through the perinatal period is limited. We provide a review of the current clinical literature...
Uloženo v:
| Vydáno v: | Curr Treat Options Psychiatry |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7880143/ https://ncbi.nlm.nih.gov/pubmed/33585165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40501-020-00221-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|